Gambol Pet Group Co. Ltd. Class A

Gambol Pet Group Co. Ltd. Class A

SSZSE:301498
34.19
CNY
+0.27
(+0.80%)
0.93EPS
41.44P/E
15.51BMarket Cap
Apr 20Next Earn
Gambol Pet Group Co. Ltd. Class A
SZSE:301498
(Shenzhen Stock Exchange)

Recent

price

34.19

P/E

ratio

41.44

div

yld

1.48%

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
4.11
3.37
5.6
7.16
9.42
11.6
13.1
16.89
17.9
Revenue per Share
0.15
0.01
0.31
0.39
0.74
1.15
1.56
1.68
0.93
Basic EPS, GAAP
-0.84
-0.83
-0.1
-0.01
0.35
1.13
0.1
0.36
- -
Free Cash Flow per Basic Share
0.06
0.06
0.06
0.05
0.03
- -
0.42
0.5
0.51
Dividend per Share
1.87
3.02
3.74
4.09
4.88
9.16
10.36
11.59
11.4
Book Value per Share
1.55
2.71
3.45
3.77
4.57
8.83
9.95
11.19
10.36
Tangible Book Value per Share
297
416
360
360
361
373
400
401
400
Basic Weighted Avg Shares
1,221
1,403
2,013
2,575
3,398
4,327
5,245
6,769
7,156
Sales/Revenue/Turnover
7.61
1.38
8.08
7.62
9.15
12.47
14.6
12.48
7.77
Operating Margin (%)
33
38
51
83
92
103
112
154
- -
Depreciation Expense
45
4
111
140
267
429
625
673
374
Net Income, GAAP
41.25
59.22
17.73
20.62
16.43
18.07
22.66
23.61
27.56
Effective Tax Rate (%)
3.65
0.3
5.54
5.45
7.86
9.91
11.91
9.94
5.22
Profit Margin (%)
20
389
435
513
746
1,737
1,322
2,224
1,679
Working Capital
- -
178
78
54
31
21
64
56
278
LT Debt
674
1,088
1,347
1,476
1,759
3,670
4,151
4,643
4,564
Total Equity
- -
0.37
7.28
7.36
13.79
15.21
15.47
14.14
6.92
Return on Invested Capital (%)
- -
1.93
10.77
12.03
14.77
15.15
15.52
14.45
7.12
Return on Capital (%)
- -
0.47
9.15
9.95
16.54
15.82
16
15.32
8.3
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
577
929
1,274
LT Borrowings
- -
24
34
LT Finance Leases
243
241
244
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
400
400
400
Market Capitalization
20,412
16,255
15,514

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
3,382
3,650
3,744
Cash, Cash Equivalents & STI
771
985
1,313
Accounts Receivable, Net
394
536
490
Inventories
1,013
921
1,155
Total Current Liabilities
1,243
1,712
2,065
Payables & Accruals
- -
- -
- -
ST Debt
577
929
1,274
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
32.46%
11.84%
Free Cash Flow
- -
-530.61%
264.99%
Net Income, GAAP
- -
46.04%
7.75%
Sales/Revenue/Turnover
- -
27.5%
29.06%
Total Cash Common Dividend
- -
2,224.77%
19.91%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,097
1,329
1,245
1,573
5,245
2025
1,480
1,741
- -
2,032
6,769
2026
1,644
1,899
1,582
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.37
0.4
0.4
0.39
1.56
2025
0.51
0.43
- -
0.4
1.68
2026
0.31
0.17
0.06
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.17
0.25
0.42
2025
- -
- -
- -
0.01
0.5
2026
- -
0.25
0.24
- -
- -
Business
Gambol Pet Group Co., Ltd. (301498.SZ) engages in the research, development, production and sale of pet food products primarily for dogs and cats in China. The company offers a comprehensive portfolio of core products including dry food and wet food; staple foods featuring scientific nutritional formulas; snack series utilizing livestock, poultry and fish as primary raw materials; health care products such as freeze-dried lecithin and calcium lactate formulations; treats, chews and dental bones; and its flagship Myfoodie brand, which leads China's pet treat category and ranks prominently in dry food. Gambol operates three R&D centers and 18 factories in China plus two in Thailand, producing over 182,000 tons annually across 1,300 product varieties that it exports as a major OEM/ODM and private-label supplier to 33 countries in Europe, North America, Japan, South Korea and beyond, serving key clients like Walmart in the US. Founded in 2006 and headquartered in Liaocheng, Shandong Province, China, the company targets pet owners, retailers and global brands in the fast-growing pet nutrition sector with a focus on precision nutrition solutions for immunity, gut health, oral care, bone strength and life-stage needs. Recent developments include a strategic investment partnership with KKR to expand production capacity in China, Thailand, Europe and the US; its 2023 listing on the Shenzhen Stock Exchange GEM board; and a November 2025 announcement of a 950 million yuan investment in a new pet food project in New Zealand to further global operations.